MedPath

Experimentation of Sensorized Pseudoelastic Orthoses Produced by Additive Manufacturing

Not Applicable
Recruiting
Conditions
Acquired Brain Injury
Registration Number
NCT04328857
Lead Sponsor
IRCCS Eugenio Medea
Brief Summary

The proposed clinical investigation plan is a pivotal controlled study with two parallel groups, has a total duration of 12 months and involves the recruitment of 34 pediatric patients suffering from acquired brain injury.

The primary objective of the clinical study is to evaluate the improvement of joint stiffness through the use of sensorized pseudoelastic orthoses for the rehabilitation of pediatric patients with acquired brain injury.

The effectiveness of the treatment in terms of joint stiffness (primary outcome) will be assessed and the effect of the treatment will be quantified with clinical evaluation scales and instrumental measurements by means of an optoelectronic system and isokinetic machine. The tolerability and acceptability of the device will also be checked.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
34
Inclusion Criteria
  1. Quadriplegia or acquired hemiplegia.
  2. Age 6-20 years.
  3. Dystonic, dyskinetic, spastic.
  4. Chronic phase patients (> 1 year post event).
  5. Spastic syndrome with Ashworth Score (AS) for the limb of interest> 1.
  6. Collaborative.
Exclusion Criteria
  1. Fixed limitations of the joint.
  2. Joint pain.
  3. Skin allergies.
  4. Behavioral and psychiatric disorders (eg, emotional problems, anxiety, panic attacks).

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Joint Stiffness of affected upper limb jointAfter 4 weeks of treatment

Quantitative measure performed by means of an isokinetic machine (Unit of measure: Nm/°). Changes in joint stiffness following the use of new customized devices during a rehabilitation treatment period. Lower stiffness is better.

Secondary Outcome Measures
NameTimeMethod
Melbourne Upper Limb Assessment 2After 4 weeks of treatment

Clinical scale for evaluating quality of upper limb movement (16 items, each assessed from 0 to 4 points). Result reported in %. Higher is better.

Range of motion of target joint during a pointing-forward taskAfter 4 weeks of treatment

Measured in degrees. A kinematic analysis will be performed during a pointing-forward task using an optoelectronic system.

Active range of motionAfter 4 weeks of treatment

Measured with goniometer in degrees.

Passive range of motionAfter 4 weeks of treatment

Measured with goniometer in degrees.

Quality of Upper Extremity Skills TestAfter 4 weeks of treatment

Clinical scale evaluating the quality of upper extremity function (33 items, 4 domains). Minimum score 0, maximum score 100. Higher is better.

Modified Ashworth ScaleAfter 4 weeks of treatment

Clinical scale for spasticity (5 levels), higher is worse.

Trial Locations

Locations (1)

IRCCS Eugenio Medea

🇮🇹

Bosisio Parini, LC, Italy

IRCCS Eugenio Medea
🇮🇹Bosisio Parini, LC, Italy
Elena Beretta, MD
Contact
+39031877111
elena.beretta@lanostrafamiglia.it
Fabio A Storm
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.